Joanna Chataway
Biographic Data
| ID | 204906 |
|---|---|
| NAME | Joanna Chataway |
| GIVEN NAMES | Joanna |
| FAMILY NAME | Chataway |
| SIGNATURE | CHATAWAY J |
| AFFILIATIONS | The Open University |
| ORCID | 0000-0002-5370-4007 |
| VERIFIED | Yes |
| TOTAL WORKS | 12 |
| TOTAL CITATIONS | 104 |
| AUTHOR COUNT | 12 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1993 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 4 |
Cross-disease spillover from research funding: Evidence from four diseases
There is widespread appreciation for the role of research in addressing health problems. However, there is limited evidence on the extent to which research can be targeted to specific diseases. Analyses highlighting a concentration of research funding towards certain diseases have prompted growing scrutiny over the allocation of research funding. In this paper, we show that research funding targeted to a disease often results in publications rela…
Harnessing innovative HIV point-of-care testing for health systems strengthening: Early lessons from Zimbabwe
Questions linking social needs with new technologies have continued to be raised but only very recently have they begun to occupy more of the centre-stage in innovation policy debates. In this narrative review, we draw from innovation and health systems literature and thinking to trace and analyse the deployment and uptake of innovative point-of-care testing in the early infant diagnosis of HIV in Zimbabwe, one of 15 UNITAID supported early adopt…
Evaluating a complex research capacity-building intervention: Reflections on an evaluation of the African Institutions Initiative
There is increasing policy demand for real-time evaluations of research and capacity-building programmes reflecting a recognition of the management, governance and impact gains that can result. However, the evidence base on how to successfully implement real-time evaluations of complex interventions in international development efforts is scarce. There is therefore a need for reflective work that considers methodologies in context. This article s…
Attitudes to vaccination: A critical review
This paper provides a consolidated overview of public and healthcare professionals' attitudes towards vaccination in Europe by bringing together for the first time evidence across various vaccines, countries and populations. The paper relies on an extensive review of empirical literature published in English after 2009, as well as an analysis of unpublished market research data from member companies of Vaccines Europe. Our synthesis suggests that…
Inclusive innovation: An Architecture for Policy Development
The past two decades have been characterized by an increasing uncoupling of economic growth and social and economic development. Outside of China, the numbers living in absolute poverty have remained stubbornly large; in Africa, they have increased substantially. Although this uncoupling has multiple sources, the trajectory of innovation (large in scale, capital intensive in nature and destructive of the environment) has contributed to these outc…
New drugs and health technologies for low-income populations: Will the Private Sector Meet the Needs of Low-Income Populations in Developing Countries
This paper argues that the development of targeted health technologies for poor people will require a new mix of technology, organizations and institutions which we conceptualize as new social technologies. Using a technology–market matrix, we explore these new social technologies which may sometimes include multi-national companies but are also associated with developing country private sector firms and not-for-profit product development partner…
Issues in the Political Economy of Agricultural Biotechnology
Agricultural biotechnology is typically analyzed critically by means of a political ecological focus on the science and its ecological implications - agbio science as a radical, and 'non-natural', break with 'normal' trajectories for 'new plant science'. Surprisingly, less attention has been paid to a range of key political economic issues, many of which were important in the last big food production technology 'revolution', the Green Revolution.…
The International Aids Vaccine Initiative (Iavi) in a Changing Landscape of Vaccine Development: A Public/Private Partnership as Knowledge Broker and Integrator
Promoting Innovation, Productivity and Industrial Growth and Reducing Poverty: Bridging the Policy Gap
The International Aids Vaccine Initiative (Iavi): Is It Getting New Science and Technology to the World’s Neglected Majority
Participation, Communication and Innovation: Thinking About the International Aids Vaccine Initiative
This article is an attempt to think about participation not as an event but rather as part of an effort to build systems and institutions in science, technology and innovation in developing countries. It uses two notions of participation, one as a mechanism to facilitate democracy and broader control and another as a means to achieve development goals. The article looks at the International AIDS Vaccine Initiative (IAVI) and in particular conside…
Is risk regulation a strategic influence on decision making in the biotechnology industry
Inclusive innovation: An Architecture for Policy Development
The past two decades have been characterized by an increasing uncoupling of economic growth and social and economic development. Outside of China, the numbers living in absolute poverty have remained stubbornly large; in Africa, they have increased substantially. Although this uncoupling has multiple sources, the trajectory of innovation (large in scale, capital intensive in nature and destructive of the environment) has contributed to these outc…
Issues in the Political Economy of Agricultural Biotechnology
Agricultural biotechnology is typically analyzed critically by means of a political ecological focus on the science and its ecological implications - agbio science as a radical, and 'non-natural', break with 'normal' trajectories for 'new plant science'. Surprisingly, less attention has been paid to a range of key political economic issues, many of which were important in the last big food production technology 'revolution', the Green Revolution.…
The International Aids Vaccine Initiative (Iavi): Is It Getting New Science and Technology to the World’s Neglected Majority
Evaluating a complex research capacity-building intervention: Reflections on an evaluation of the African Institutions Initiative
There is increasing policy demand for real-time evaluations of research and capacity-building programmes reflecting a recognition of the management, governance and impact gains that can result. However, the evidence base on how to successfully implement real-time evaluations of complex interventions in international development efforts is scarce. There is therefore a need for reflective work that considers methodologies in context. This article s…
The International Aids Vaccine Initiative (Iavi) in a Changing Landscape of Vaccine Development: A Public/Private Partnership as Knowledge Broker and Integrator
Promoting Innovation, Productivity and Industrial Growth and Reducing Poverty: Bridging the Policy Gap
New drugs and health technologies for low-income populations: Will the Private Sector Meet the Needs of Low-Income Populations in Developing Countries
This paper argues that the development of targeted health technologies for poor people will require a new mix of technology, organizations and institutions which we conceptualize as new social technologies. Using a technology–market matrix, we explore these new social technologies which may sometimes include multi-national companies but are also associated with developing country private sector firms and not-for-profit product development partner…
Harnessing innovative HIV point-of-care testing for health systems strengthening: Early lessons from Zimbabwe
Questions linking social needs with new technologies have continued to be raised but only very recently have they begun to occupy more of the centre-stage in innovation policy debates. In this narrative review, we draw from innovation and health systems literature and thinking to trace and analyse the deployment and uptake of innovative point-of-care testing in the early infant diagnosis of HIV in Zimbabwe, one of 15 UNITAID supported early adopt…
Is risk regulation a strategic influence on decision making in the biotechnology industry
Cross-disease spillover from research funding: Evidence from four diseases
There is widespread appreciation for the role of research in addressing health problems. However, there is limited evidence on the extent to which research can be targeted to specific diseases. Analyses highlighting a concentration of research funding towards certain diseases have prompted growing scrutiny over the allocation of research funding. In this paper, we show that research funding targeted to a disease often results in publications rela…
Participation, Communication and Innovation: Thinking About the International Aids Vaccine Initiative
This article is an attempt to think about participation not as an event but rather as part of an effort to build systems and institutions in science, technology and innovation in developing countries. It uses two notions of participation, one as a mechanism to facilitate democracy and broader control and another as a means to achieve development goals. The article looks at the International AIDS Vaccine Initiative (IAVI) and in particular conside…
Is risk regulation a strategic influence on decision making in the biotechnology industry
The International Aids Vaccine Initiative (Iavi): Is It Getting New Science and Technology to the World’s Neglected Majority
Participation, Communication and Innovation: Thinking About the International Aids Vaccine Initiative
This article is an attempt to think about participation not as an event but rather as part of an effort to build systems and institutions in science, technology and innovation in developing countries. It uses two notions of participation, one as a mechanism to facilitate democracy and broader control and another as a means to achieve development goals. The article looks at the International AIDS Vaccine Initiative (IAVI) and in particular conside…
The International Aids Vaccine Initiative (Iavi) in a Changing Landscape of Vaccine Development: A Public/Private Partnership as Knowledge Broker and Integrator
Promoting Innovation, Productivity and Industrial Growth and Reducing Poverty: Bridging the Policy Gap
Issues in the Political Economy of Agricultural Biotechnology
Agricultural biotechnology is typically analyzed critically by means of a political ecological focus on the science and its ecological implications - agbio science as a radical, and 'non-natural', break with 'normal' trajectories for 'new plant science'. Surprisingly, less attention has been paid to a range of key political economic issues, many of which were important in the last big food production technology 'revolution', the Green Revolution.…
New drugs and health technologies for low-income populations: Will the Private Sector Meet the Needs of Low-Income Populations in Developing Countries
This paper argues that the development of targeted health technologies for poor people will require a new mix of technology, organizations and institutions which we conceptualize as new social technologies. Using a technology–market matrix, we explore these new social technologies which may sometimes include multi-national companies but are also associated with developing country private sector firms and not-for-profit product development partner…
Attitudes to vaccination: A critical review
This paper provides a consolidated overview of public and healthcare professionals' attitudes towards vaccination in Europe by bringing together for the first time evidence across various vaccines, countries and populations. The paper relies on an extensive review of empirical literature published in English after 2009, as well as an analysis of unpublished market research data from member companies of Vaccines Europe. Our synthesis suggests that…
Inclusive innovation: An Architecture for Policy Development
The past two decades have been characterized by an increasing uncoupling of economic growth and social and economic development. Outside of China, the numbers living in absolute poverty have remained stubbornly large; in Africa, they have increased substantially. Although this uncoupling has multiple sources, the trajectory of innovation (large in scale, capital intensive in nature and destructive of the environment) has contributed to these outc…
Evaluating a complex research capacity-building intervention: Reflections on an evaluation of the African Institutions Initiative
There is increasing policy demand for real-time evaluations of research and capacity-building programmes reflecting a recognition of the management, governance and impact gains that can result. However, the evidence base on how to successfully implement real-time evaluations of complex interventions in international development efforts is scarce. There is therefore a need for reflective work that considers methodologies in context. This article s…
Harnessing innovative HIV point-of-care testing for health systems strengthening: Early lessons from Zimbabwe
Questions linking social needs with new technologies have continued to be raised but only very recently have they begun to occupy more of the centre-stage in innovation policy debates. In this narrative review, we draw from innovation and health systems literature and thinking to trace and analyse the deployment and uptake of innovative point-of-care testing in the early infant diagnosis of HIV in Zimbabwe, one of 15 UNITAID supported early adopt…
Cross-disease spillover from research funding: Evidence from four diseases
There is widespread appreciation for the role of research in addressing health problems. However, there is limited evidence on the extent to which research can be targeted to specific diseases. Analyses highlighting a concentration of research funding towards certain diseases have prompted growing scrutiny over the allocation of research funding. In this paper, we show that research funding targeted to a disease often results in publications rela…
Political science (9 works) · Economics (8 works) · Business (5 works) · Economic growth (5 works) · Medicine (5 works) · Computer Science (4 works) · Innovation and Socioeconomic Development (4 works) · Law (4 works) · Context (archaeology (3 works) · Nursing (3 works)